| Jagdip Desai, MD | |
|
1 Clara Maass Dr, Anesthesia Department, Belleville, NJ 07109-3550 | |
| (908) 705-6857 | |
| Not Available |
| Full Name | Jagdip Desai |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 23 Years |
| Location | 1 Clara Maass Dr, Belleville, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194761593 | NPI | - | NPPES |
| PENDING | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 25MA07787200 (New Jersey) | Secondary |
| 207LP2900X | Anesthesiology - Pain Medicine | 25MA07787200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverview Medical Center | Red bank, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Core Medical Group, Llc | 7214279439 | 4 |
| Gabriele Jasper Md, Inc | 2365538618 | 4 |
| Red Bank Anesthesia, Llc | 2567520380 | 24 |
News Archive
Loyola University Chicago Stritch School of Medicine is playing an integral role in providing specialized training and support for medical students who are preparing to serve as physicians in the U.S. military.
New research has been published indicating that patients suffering from a painful complication of diabetes may experience a significant improvement in their pain as measured by a pain intensity scale when using an investigational pain medication.
A combined positron emission tomography-computed tomography (PET-CT) scan of the whole body appears to detect cancer in individuals with related neurologic complications more accurately than some other commonly used tests, according to a report posted online today that will appear in the March print issue of Archives of Neurology, one of the JAMA/Archives journals.
Cubist Pharmaceuticals, Inc. today announced the early closing of enrollment in its ecallantide Phase 2 program. Ecallantide, in development as therapy to reduce bleeding in on-pump cardiac surgery, is now known as CB-500,929. After a regularly scheduled review meeting, the Data Safety Monitoring Board (DSMB) contacted the company to recommend a temporary suspension in enrollment in one of the CB-500,929 trials, CONSERV-2.
› Verified 7 days ago
| Entity Name | Gabriele Jasper Md, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053500041 PECOS PAC ID: 2365538618 Enrollment ID: O20071017000659 |
News Archive
Loyola University Chicago Stritch School of Medicine is playing an integral role in providing specialized training and support for medical students who are preparing to serve as physicians in the U.S. military.
New research has been published indicating that patients suffering from a painful complication of diabetes may experience a significant improvement in their pain as measured by a pain intensity scale when using an investigational pain medication.
A combined positron emission tomography-computed tomography (PET-CT) scan of the whole body appears to detect cancer in individuals with related neurologic complications more accurately than some other commonly used tests, according to a report posted online today that will appear in the March print issue of Archives of Neurology, one of the JAMA/Archives journals.
Cubist Pharmaceuticals, Inc. today announced the early closing of enrollment in its ecallantide Phase 2 program. Ecallantide, in development as therapy to reduce bleeding in on-pump cardiac surgery, is now known as CB-500,929. After a regularly scheduled review meeting, the Data Safety Monitoring Board (DSMB) contacted the company to recommend a temporary suspension in enrollment in one of the CB-500,929 trials, CONSERV-2.
› Verified 7 days ago
| Entity Name | Metropolitan Pain Consultants, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639355621 PECOS PAC ID: 6204906985 Enrollment ID: O20080606000532 |
News Archive
Loyola University Chicago Stritch School of Medicine is playing an integral role in providing specialized training and support for medical students who are preparing to serve as physicians in the U.S. military.
New research has been published indicating that patients suffering from a painful complication of diabetes may experience a significant improvement in their pain as measured by a pain intensity scale when using an investigational pain medication.
A combined positron emission tomography-computed tomography (PET-CT) scan of the whole body appears to detect cancer in individuals with related neurologic complications more accurately than some other commonly used tests, according to a report posted online today that will appear in the March print issue of Archives of Neurology, one of the JAMA/Archives journals.
Cubist Pharmaceuticals, Inc. today announced the early closing of enrollment in its ecallantide Phase 2 program. Ecallantide, in development as therapy to reduce bleeding in on-pump cardiac surgery, is now known as CB-500,929. After a regularly scheduled review meeting, the Data Safety Monitoring Board (DSMB) contacted the company to recommend a temporary suspension in enrollment in one of the CB-500,929 trials, CONSERV-2.
› Verified 7 days ago
| Entity Name | North American Partners In Anesthesia Of New Jersey Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548433048 PECOS PAC ID: 5890867410 Enrollment ID: O20080626000318 |
News Archive
Loyola University Chicago Stritch School of Medicine is playing an integral role in providing specialized training and support for medical students who are preparing to serve as physicians in the U.S. military.
New research has been published indicating that patients suffering from a painful complication of diabetes may experience a significant improvement in their pain as measured by a pain intensity scale when using an investigational pain medication.
A combined positron emission tomography-computed tomography (PET-CT) scan of the whole body appears to detect cancer in individuals with related neurologic complications more accurately than some other commonly used tests, according to a report posted online today that will appear in the March print issue of Archives of Neurology, one of the JAMA/Archives journals.
Cubist Pharmaceuticals, Inc. today announced the early closing of enrollment in its ecallantide Phase 2 program. Ecallantide, in development as therapy to reduce bleeding in on-pump cardiac surgery, is now known as CB-500,929. After a regularly scheduled review meeting, the Data Safety Monitoring Board (DSMB) contacted the company to recommend a temporary suspension in enrollment in one of the CB-500,929 trials, CONSERV-2.
› Verified 7 days ago
| Entity Name | Red Bank Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871764530 PECOS PAC ID: 2567520380 Enrollment ID: O20081023000423 |
News Archive
Loyola University Chicago Stritch School of Medicine is playing an integral role in providing specialized training and support for medical students who are preparing to serve as physicians in the U.S. military.
New research has been published indicating that patients suffering from a painful complication of diabetes may experience a significant improvement in their pain as measured by a pain intensity scale when using an investigational pain medication.
A combined positron emission tomography-computed tomography (PET-CT) scan of the whole body appears to detect cancer in individuals with related neurologic complications more accurately than some other commonly used tests, according to a report posted online today that will appear in the March print issue of Archives of Neurology, one of the JAMA/Archives journals.
Cubist Pharmaceuticals, Inc. today announced the early closing of enrollment in its ecallantide Phase 2 program. Ecallantide, in development as therapy to reduce bleeding in on-pump cardiac surgery, is now known as CB-500,929. After a regularly scheduled review meeting, the Data Safety Monitoring Board (DSMB) contacted the company to recommend a temporary suspension in enrollment in one of the CB-500,929 trials, CONSERV-2.
› Verified 7 days ago
| Entity Name | Jasper Ambulatory Surgical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1194950915 PECOS PAC ID: 2860544350 Enrollment ID: O20090714000584 |
News Archive
Loyola University Chicago Stritch School of Medicine is playing an integral role in providing specialized training and support for medical students who are preparing to serve as physicians in the U.S. military.
New research has been published indicating that patients suffering from a painful complication of diabetes may experience a significant improvement in their pain as measured by a pain intensity scale when using an investigational pain medication.
A combined positron emission tomography-computed tomography (PET-CT) scan of the whole body appears to detect cancer in individuals with related neurologic complications more accurately than some other commonly used tests, according to a report posted online today that will appear in the March print issue of Archives of Neurology, one of the JAMA/Archives journals.
Cubist Pharmaceuticals, Inc. today announced the early closing of enrollment in its ecallantide Phase 2 program. Ecallantide, in development as therapy to reduce bleeding in on-pump cardiac surgery, is now known as CB-500,929. After a regularly scheduled review meeting, the Data Safety Monitoring Board (DSMB) contacted the company to recommend a temporary suspension in enrollment in one of the CB-500,929 trials, CONSERV-2.
› Verified 7 days ago
| Entity Name | Core Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003328824 PECOS PAC ID: 7214279439 Enrollment ID: O20190508001389 |
News Archive
Loyola University Chicago Stritch School of Medicine is playing an integral role in providing specialized training and support for medical students who are preparing to serve as physicians in the U.S. military.
New research has been published indicating that patients suffering from a painful complication of diabetes may experience a significant improvement in their pain as measured by a pain intensity scale when using an investigational pain medication.
A combined positron emission tomography-computed tomography (PET-CT) scan of the whole body appears to detect cancer in individuals with related neurologic complications more accurately than some other commonly used tests, according to a report posted online today that will appear in the March print issue of Archives of Neurology, one of the JAMA/Archives journals.
Cubist Pharmaceuticals, Inc. today announced the early closing of enrollment in its ecallantide Phase 2 program. Ecallantide, in development as therapy to reduce bleeding in on-pump cardiac surgery, is now known as CB-500,929. After a regularly scheduled review meeting, the Data Safety Monitoring Board (DSMB) contacted the company to recommend a temporary suspension in enrollment in one of the CB-500,929 trials, CONSERV-2.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jagdip Desai, MD 51 Raritan Reach Rd, South Amboy, NJ 08879-3440 Ph: (732) 709-3215 | Jagdip Desai, MD 1 Clara Maass Dr, Anesthesia Department, Belleville, NJ 07109-3550 Ph: (908) 705-6857 |
News Archive
Loyola University Chicago Stritch School of Medicine is playing an integral role in providing specialized training and support for medical students who are preparing to serve as physicians in the U.S. military.
New research has been published indicating that patients suffering from a painful complication of diabetes may experience a significant improvement in their pain as measured by a pain intensity scale when using an investigational pain medication.
A combined positron emission tomography-computed tomography (PET-CT) scan of the whole body appears to detect cancer in individuals with related neurologic complications more accurately than some other commonly used tests, according to a report posted online today that will appear in the March print issue of Archives of Neurology, one of the JAMA/Archives journals.
Cubist Pharmaceuticals, Inc. today announced the early closing of enrollment in its ecallantide Phase 2 program. Ecallantide, in development as therapy to reduce bleeding in on-pump cardiac surgery, is now known as CB-500,929. After a regularly scheduled review meeting, the Data Safety Monitoring Board (DSMB) contacted the company to recommend a temporary suspension in enrollment in one of the CB-500,929 trials, CONSERV-2.
› Verified 7 days ago
Jose Alberto De Trespalacios, DO Anesthesiology Medicare: Medicare Enrolled Practice Location: 1 Clara Maass Dr, Belleville, NJ 07109 Phone: 908-653-9399 Fax: 908-653-9305 | |
Lissette Lugo, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Clara Maass Dr, Belleville, NJ 07109 Phone: 212-302-4399 Fax: 212-302-2582 | |
Maged Moussa Gerges, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Clara Maass Drive, Belleville, NJ 07109 Phone: 908-653-9399 Fax: 908-853-9305 | |
Muhammad Bakhtiar Husain Khan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Clara Maass Dr, Belleville, NJ 07109 Phone: 908-653-9399 Fax: 908-653-9305 | |
Jolanta Rejowska Cedrowski, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Clara Maass Drive, Belleville, NJ 07109 Phone: 908-653-9399 Fax: 908-653-9305 | |
Jennifer Marcus, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: One Clara Maass Dr, Belleville, NJ 07109 Phone: 908-653-9399 Fax: 908-653-9305 |